SCHEMBL1964510

SCHEMBL1964510

Nc1c(Cl)cc(CO)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 3/20 0.50
ACHE P22303 1/20 0.42
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
RECQL P46063 1/20 0.37
LMNA P02545 2/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR1A P08908 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
OPRK1 P41145 1/20 0.36
SLC6A3 Q01959 1/20 0.36
TSHR P16473 1/20 0.36
KDM4E B2RXH2 3/20 0.35
GAA P10253 3/20 0.35
GLA P06280 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3519402 0.84 CA1 (0.46) ALDH1A1CYP3A4ACHECA1CA2
SCHEMBL3005448 0.81 CYP3A4 (0.52) ALDH1A1CYP3A4CA1CA2CA9
SCHEMBL3311587 0.80 ADRB2 (0.49) ADRB2ADRB1
Hydrochloric Acid SCHEMBL2986953 0.79 CYP3A4 (0.50) ALDH1A1CYP3A4CA1CA2CA9
SCHEMBL1965439 0.78 HPGD (0.48) ALDH1A1CYP3A4ACHERECQLLMNA
SCHEMBL940822 0.78 ALDH1A1 (0.55) ALDH1A1CYP3A4CA1CA2CA9
SCHEMBL522619 0.76 ACHE (0.43) CYP3A4ACHECA2RECQLLMNA
SCHEMBL670342 0.76 ACHE (0.43) CYP3A4ACHECA2RECQLTSHR
SCHEMBL737479 0.76 HSD17B10 (0.52) ALDH1A1CYP3A4ACHERECQLLMNA
SCHEMBL3191004 0.76 CYP3A4 (0.52) ALDH1A1CYP3A4CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119977778-A Preparation method of carboxyamidotriazole intermediate 广东银珠医药科技有限公司 2025-05-13 CN claimed
EP-0196849-A2 Aminohydroxyalkylbenzene anti-obesity and/or anti-hyperglycaemic agents BEECHAM GROUP PLC (GB) 1986-10-08 EP claimed
CN-119977778-A Preparation method of carboxyamidotriazole intermediate 广东银珠医药科技有限公司 2025-05-13 CN disclosed
WO-2017042121-A1 [{[2,3-DIHYDRO-1H-INDEN-1-YL]AMINO}-2H,3H-FURO[3,2-B]PYRIDIN-3-YL]ACETIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-03-16 WO disclosed
WO-2017025368-A1 INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-02-16 WO disclosed
EP-2350097-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2011-08-03 EP disclosed
US-20110166152-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-07-07 US disclosed
US-20110152295-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-06-23 US disclosed
EP-2334666-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Canada Inc. (CA) 2011-06-22 EP disclosed
WO-2010037225-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-04-08 WO disclosed
WO-2010025553-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-03-11 WO disclosed
US-20050085509-A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient ONO PHARMACEUTICAL CO. LTD. (JP) 2005-04-21 US disclosed
EP-1447401-A1 PIPERIDIN-2-ONE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-08-18 EP disclosed
EP-0679645-A1 Pharmacologically active CNS pyridmidin compounds THE WELLCOME FOUNDATION LIMITED (GB) 1995-11-02 EP disclosed
EP-0459819-A2 Pharmacologically active CNS compound THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-04 EP disclosed
EP-0230532-B1 2-[(3,5-Dihalo-4-Aminobenzyl)] Imidazolines ABBOTT LABORATORIES (US) 1990-09-26 EP disclosed
EP-0230532-A1 2-[(3,5-Dihalo-4-Aminobenzyl)] Imidazolines ABBOTT LABORATORIES (US) 1987-08-05 EP disclosed
US-4665095-A Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion ABBOTT LABORATORIES (US) 1987-05-12 US disclosed
EP-0196849-A2 Aminohydroxyalkylbenzene anti-obesity and/or anti-hyperglycaemic agents BEECHAM GROUP PLC (GB) 1986-10-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166152-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, CPT1A ALDH1A1 792/4885CYP3A4 564/4885ACHE 3477/4885
US-20050085509-A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient MAPKAP1, MAPK1, MAPK8 ALDH1A1 2969/4885CYP3A4 4535/4885ACHE 3730/4885
US-20110152295-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, SREBF1 ALDH1A1 518/4885CYP3A4 639/4885ACHE 3612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.